ABOUT US
In the beginning there was a small group of dedicated scientists who were wondering if it was possible to change the way people monitor their health.
CO-OP
They created a Highly Specialized Molecular Testing Company based on Co-operation
AVAILABLE FOR EVERYONE
Since Genomic testing is expensive and risky for smaller labs they established GTC, a genomic testing lab combining next-gen sequencing (NGS) with AI that will disrupt the current model.
Previous
Next

OUR STORY

GTC WAS FOUNDED IN 2018

OUR MISSION

We offer advanced genomic profiling for both solid and hematologic cancers to communities everywhere at an affordable price.

We utilize a cooperative business model  to help physicians treat patients locally with the most advanced precision medicine.

We embrace disruptive deep learning and advanced technology to create scalable efficiencies, incomparable precision, and a more personalized approach to patient care.

OUR VISION

We are committed to driving the field of oncology forward by enabling more patients to contribute their unique cancer experience to the growing body of cancer genomics data.

We are committed to fulfilling precision medicine’s promise of individualized care for everyone by empowering physicians to formulate treatments that best suit each patient’s unique genetic profile.

CAP Accredited

MEET OUR LEADING TEAM

OUR TEAM HAS DECADES OF EXPERIENCE WORKING IN DIAGNOSTICS

MAKING GENOMICS AVAILABLE AND AFFORDABLE TO EVERYONE

5 Reasons

that make GTC Unique
Monitoring Health
Diagnosis & Classifications
Selecting Therapy (CDX)
Predicting Prognosis
Monitoring Therapy
GTC Tests

Our Aim

is to offer you
Precision Medicine
Immune Profiling
Immunotherapy
Genetic Predisposition
Learn More

HOW WE DO THAT?

Machine / Deep Learning (AI) is the center of our analysis